Ausgabe 1/2011
Inhalt (37 Artikel)
High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions
Ana Teresa Martins, Paula Monteiro, João Ramalho-Carvalho, Vera L. Costa, Mário Dinis-Ribeiro, Conceição Leal, Rui Henrique, Carmen Jerónimo
FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer
Hany Onsy Habashy, Emad A. Rakha, Mohammed Aleskandarany, Mohamed AH Ahmed, Andrew R. Green, Ian O. Ellis, Desmond G. Powe
Effects of estrogen on the proportion of stem cells in the breast
Bruno M. Simões, Marco Piva, Oihana Iriondo, Valentine Comaills, Jose A. López-Ruiz, Iñaki Zabalza, Jon A. Mieza, Olga Acinas, Maria d.M. Vivanco
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
Sean D. McAllister, Ryuichi Murase, Rigel T. Christian, Darryl Lau, Anne J. Zielinski, Juanita Allison, Carolina Almanza, Arash Pakdel, Jasmine Lee, Chandani Limbad, Yong Liu, Robert J. Debs, Dan H. Moore, Pierre-Yves Desprez
MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirements
Sebastián Giulianelli, Jason I. Herschkowitz, Vyomesh Patel, Caroline A. Lamb, J. Silvio Gutkind, Alfredo Molinolo, Charles M. Perou, Claudia Lanari
BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation
Takashi Iwamoto, Noriaki Yamamoto, Tetsuya Taguchi, Yasuhiro Tamaki, Shinzaburo Noguchi
The benefits of discussing adjuvant therapies one at a time instead of all at once
Brian J. Zikmund-Fisher, Andrea M. Angott, Peter A. Ubel
Clinical application of shear wave elastography (SWE) in the diagnosis of benign and malignant breast diseases
Jung Min Chang, Woo Kyung Moon, Nariya Cho, Ann Yi, Hye Ryoung Koo, Wonsik Han, Dong-Young Noh, Hyeong-Gon Moon, Seung Ja Kim
Time for a re-evaluation of mammography in the young? Results of an audit of mammography in women younger than 40 in a resource restricted environment
Liezel Taylor, Sarinah Basro, Justus P. Apffelstaedt, Karin Baatjes
Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial
Antonella L. Rastelli, Marie E. Taylor, Feng Gao, Reina Armamento-Villareal, Shohreh Jamalabadi-Majidi, Nicola Napoli, Matthew J. Ellis
Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer
Catherine Schairer, Linda M. Brown, Phuong L. Mai
Long-term quality of life after breast cancer: a French registry-based controlled study
Delphine Klein, Mariette Mercier, Edwige Abeilard, Marc Puyraveau, Arlette Danzon, Véronique Dalstein, Astrid Pozet, Anne-Valérie Guizard, Michel Henry-Amar, Michel Velten
Alcohol, tobacco, and mammographic density: a population-based study
Anna Cabanes, Roberto Pastor-Barriuso, Milagros García-López, Carmen Pedraz-Pingarrón, Carmen Sánchez-Contador, Jose Antonio Vázquez Carrete, María Pilar Moreno, Carmen Vidal, Dolores Salas, Josefa Miranda-García, Mercé Peris, Pilar Moreo, María Carmen Santamariña, Francisca Collado-García, Isabel Gonzalez-Román , Nieves Ascunce, Marina Pollan
Mouse mammary tumor like virus sequences in breast milk from healthy lactating women
Harpreet Johal, Caroline Ford, Wendy Glenn, Joy Heads, James Lawson, William Rawlinson
Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy
Ingrid E. Fakkert, Liesbeth Jansen, Kees Meijer, Theo Kok, Jan C. Oosterwijk, Marian J. E. Mourits, Geertruida H. de Bock
Characterizing the impact of 25 years of DCIS treatment
Elissa M. Ozanne, Yiwey Shieh, James Barnes, Colleen Bouzan, E. Shelley Hwang, Laura J. Esserman
The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses’ Health Study
Ying Liu, Rulla M. Tamimi, Laura C. Collins, Stuart J. Schnitt, Hannah L. Gilmore, James L. Connolly, Graham A. Colditz
Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women
E. Comen, M. Davids, T. Kirchhoff, C. Hudis, K. Offit, M. Robson
The association between IGF1 CA repeat polymorphisms and breast cancer risk: a meta-analysis
Qiang Huang, Cheng Wang, Lu-Jun Qiu, Feng Shao, Ji-Hai Yu
PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China
Zhang Hua, Dalin Li, Gao Xiang, Fengyan Xu, Guan Jie, Zhenkun Fu, Zhang Jie, Pang Da, Dianjun Li
Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case–control studies
Da-Peng Ding, Xiao-Feng He, Ying Zhang
Differential expression of prognostic biomarkers between interval and screen-detected breast cancers: does age or family history matter?
Jan T. Lowery, Tim Byers, John Kittelson, John E. Hokanson, Judy Mouchawar, John Lewin, Dan Merrick, Lisa Hines, Meenakshi Singh
Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers
S. U. Dhar, H. P. Cooper, T. Wang, B. Parks, S. A. Staggs, S. Hilsenbeck, S. E. Plon
Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands
L. de Munck, M. Schaapveld, S. Siesling, J. Wesseling, A. C. Voogd, V. C. G. Tjan-Heijnen, R. Otter, P. H. B. Willemse
Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival
Verena Varadi, Melanie Bevier, Ewa Grzybowska, Robert Johansson, Kerstin Enquist, Roger Henriksson, Dorota Butkiewicz, Jolanta Pamula-Pilat, Karolina Tecza, Kari Hemminki, Per Lenner, Asta Försti
Clinical significance of circulating tumor cells in breast cancer patients
Min Tao, Deliang Ma, Yan Li, Chong Zhou, Yan Li, Yinsheng Zhang, Weiming Duan, Xiujuan Xu, Rong Wang, Lingzhi Wu, Haiyan Liu
Mutation analysis of RAD51L1 (RAD51B/REC2) in multiple-case, non-BRCA1/2 breast cancer families
Julie Johnson, Sue Healey, Kum Kum Khanna, Georgia Chenevix-Trench
The influence of travel time on breast cancer characteristics, receipt of primary therapy, and surveillance mammography
Tracy Onega, Andrea Cook, Beth Kirlin, Xun Shi, Jennifer Alford-Teaster, Leah Tuzzio, Diana S. M. Buist
XPC gene polymorphisms and breast cancer susceptibility: appraisal of a recent meta-analysis
Fang Wang, Yan-Feng Zou, Guo-Ping Sun
The association between AURKA T91A polymorphism and breast cancer risk
Chibo Liu
Association between rs3803662 polymorphism of trinucleotide repeat containing 9 gene and breast cancer risk
Weidong Chen
Immediate reconstruction with implants in women with invasive breast cancer does not affect oncological safety in a matched cohort study
Alexandre Mendonça Munhoz, Rolf Gemperli, José Roberto Filassi
Need for clarification of data in the recent meta-analysis about p53 codon 72 polymorphism and breast cancer risk
Xiao-Feng He, Jiao Su, Wei Wang
Erratum to: Editorial: Cost-effective analyses in Breast Cancer Research and Treatment
Marc E. Lippman, Stephen Ethier, Daniel F. Hayes
Erratum to: Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network
Brian Cox, Rachel Ballard-Barbash, Mireille Broeders, Emily Dowling, Nea Malila, Rene Shumak, Stephen Taplin, Diana Buist, Diana Miglioretti